Fidelis Insurance (NYSE:FIHL) and Tian Ruixiang (NASDAQ:TIRX) Head to Head Contrast

Fidelis Insurance (NYSE:FIHLGet Free Report) and Tian Ruixiang (NASDAQ:TIRXGet Free Report) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Volatility and Risk

Fidelis Insurance has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Tian Ruixiang has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500.

Profitability

This table compares Fidelis Insurance and Tian Ruixiang’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fidelis Insurance 9.02% 8.62% 1.62%
Tian Ruixiang N/A N/A N/A

Earnings and Valuation

This table compares Fidelis Insurance and Tian Ruixiang”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fidelis Insurance $2.50 billion 0.82 $225.50 million $2.21 9.57
Tian Ruixiang $5.86 million 0.38 -$3.99 million N/A N/A

Fidelis Insurance has higher revenue and earnings than Tian Ruixiang.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Fidelis Insurance and Tian Ruixiang, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fidelis Insurance 2 3 5 0 2.30
Tian Ruixiang 1 0 0 0 1.00

Fidelis Insurance presently has a consensus price target of $22.64, suggesting a potential upside of 7.03%. Given Fidelis Insurance’s stronger consensus rating and higher probable upside, analysts plainly believe Fidelis Insurance is more favorable than Tian Ruixiang.

Institutional and Insider Ownership

82.0% of Fidelis Insurance shares are owned by institutional investors. Comparatively, 10.7% of Tian Ruixiang shares are owned by institutional investors. 39.6% of Tian Ruixiang shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Fidelis Insurance beats Tian Ruixiang on 10 of the 12 factors compared between the two stocks.

About Fidelis Insurance

(Get Free Report)

Fidelis Insurance Holdings Limited, a specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in three segments: Specialty, Reinsurance, and Bespoke segments. The Specialty segment offers aviation and aerospace, energy, marine, property direct and facultative, and other specialty risk solutions. The Reinsurance segment provides property, retrocession, and whole account reinsurance solutions. The Bespoke segment offers customized risk solutions for clients that include credit and political risk, as well as other risk transfer opportunities, including political violence and terrorism, limited cyber reinsurance, tax liabilities, title, transactional liabilities, and other bespoke solutions. Fidelis Insurance Holdings Limited was incorporated in 2014 and is headquartered in Pembroke, Bermuda.

About Tian Ruixiang

(Get Free Report)

Tian Ruixiang Holdings Ltd, together its subsidiaries, operates as an insurance broker in China and the United States. It distributes a range of insurance products, including property and casualty insurance, such as automobile, commercial property, liability, and accidental insurance; and life insurance comprising individual and group life insurances, as well as health and miscellaneous insurance. It serves individual or institutional customers. The company was founded in 2010 and is headquartered in Beijing, China.

Receive News & Ratings for Fidelis Insurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelis Insurance and related companies with MarketBeat.com's FREE daily email newsletter.